BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26451340)

  • 1. Mutations in TJP2, encoding zona occludens 2, and liver disease.
    Sambrotta M; Thompson RJ
    Tissue Barriers; 2015; 3(3):e1026537. PubMed ID: 26451340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype correlates with clinical course and outcome of children with tight junction protein 2 (TJP2) deficiency-related cholestasis.
    Lal BB; Alam S; Sibal A; Kumar K; Hosaagrahara Ramakrishna S; Shah V; Dheivamani N; Bavdekar A; Nagral A; Wadhwa N; Maria A; Shah A; Shah I; Nalwalla Z; Snehavardhan P; Srikanth KP; Gupta S; Sivaramakrishnan VM; Waikar Y; Suchismita A; Ashritha A; Sood V; Khanna R;
    Hepatology; 2024 Mar; ():. PubMed ID: 38447037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center.
    Alsohaibani FI; Peedikayil MC; Alfadley AF; Aboueissa MK; Abaalkhail FA; Alqahtani SA
    Int J Hepatol; 2023; 2023():1960152. PubMed ID: 37520499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency.
    Felzen A; van Wessel DBE; Gonzales E; Thompson RJ; Jankowska I; Shneider BL; Sokal E; Grammatikopoulos T; Kadaristiana A; Jacquemin E; Spraul A; Lipiński P; Czubkowski P; Rock N; Shagrani M; Broering D; Nicastro E; Kelly D; Nebbia G; Arnell H; Fischler B; Hulscher JBF; Serranti D; Arikan C; Polat E; Debray D; Lacaille F; Goncalves C; Hierro L; Muñoz Bartolo G; Mozer-Glassberg Y; Azaz A; Brecelj J; Dezsőfi A; Calvo PL; Grabhorn E; Hartleif S; van der Woerd WJ; Kamath BM; Wang JS; Li L; Durmaz Ö; Kerkar N; Jørgensen MH; Fischer R; Jimenez-Rivera C; Alam S; Cananzi M; Laverdure N; Ferreira CT; Guerrero FO; Wang H; Sency V; Kim KM; Chen HL; de Carvalho E; Fabre A; Bernabeu JQ; Zellos A; Alonso EM; Sokol RJ; Suchy FJ; Loomes KM; McKiernan PJ; Rosenthal P; Turmelle Y; Horslen S; Schwarz K; Bezerra JA; Wang K; Hansen BE; Verkade HJ;
    JHEP Rep; 2023 Feb; 5(2):100626. PubMed ID: 36687469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency.
    Li CZ; Ogawa H; Ng SS; Chen X; Kishimoto E; Sakabe K; Fukami A; Hu YC; Mayhew CN; Hellmann J; Miethke A; Tasnova NL; Blackford SJI; Tang ZM; Syanda AM; Ma L; Xiao F; Sambrotta M; Tavabie O; Soares F; Baker O; Danovi D; Hayashi H; Thompson RJ; Rashid ST; Asai A
    JHEP Rep; 2022 Apr; 4(4):100446. PubMed ID: 35284810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer variants of progressive familial intrahepatic cholestasis.
    Vinayagamoorthy V; Srivastava A; Sarma MS
    World J Hepatol; 2021 Dec; 13(12):2024-2038. PubMed ID: 35070006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZO-2 favors Hippo signaling, and its re-expression in the steatotic liver by AMPK restores junctional sealing.
    González-González L; Gallego-Gutiérrez H; Martin-Tapia D; Avelino-Cruz JE; Hernández-Guzmán C; Rangel-Guerrero SI; Alvarez-Salas LM; Garay E; Chávez-Munguía B; Gutiérrez-Ruiz MC; Hernández-Melchor D; López-Bayghen E; González-Mariscal L
    Tissue Barriers; 2022 Apr; 10(2):1994351. PubMed ID: 34689705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases.
    Zhou JL; Zhao YZ; Wang SS; Chen MX; Zhou S; Chen C
    Front Mol Biosci; 2021; 8():725308. PubMed ID: 34651015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Novel Pathogenic Variants of
    Tang J; Tan M; Deng Y; Tang H; Shi H; Li M; Ma W; Li J; Dai H; Li J; Zhou S; Li X; Wei F; Ma X; Luo L
    Front Cell Dev Biol; 2021; 9():661599. PubMed ID: 34504838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia.
    Abaalkhail FA; Al Sebayel MI; Shagrani MA; O'Hali WA; Almasri NM; Alalwan AA; Alghamdi MY; Al-Bahili H; AlQahtani MS; Alabbad SI; Al-Hamoudi WK; Alqahtani SA
    Saudi Med J; 2021 Sep; 42(9):927-968. PubMed ID: 34470833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tight junction stabilization prevents HepaRG cell death in drug-induced intrahepatic cholestasis.
    Sonoi R; Hagihara Y
    Biol Open; 2021 Jun; 10(6):. PubMed ID: 34151938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular overview of progressive familial intrahepatic cholestasis.
    Amirneni S; Haep N; Gad MA; Soto-Gutierrez A; Squires JE; Florentino RM
    World J Gastroenterol; 2020 Dec; 26(47):7470-7484. PubMed ID: 33384548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.
    Portincasa P; Di Ciaula A; Garruti G; Vacca M; De Angelis M; Wang DQ
    Nutrients; 2020 Nov; 12(12):. PubMed ID: 33266235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive familial intrahepatic cholestasis type 4 in an Indian child: presentation, initial course and novel compound heterozygous mutation.
    Mirza N; Bharadwaj R; Malhotra S; Sibal A
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32636225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults: A case report.
    Wei CS; Becher N; Friis JB; Ott P; Vogel I; Grønbæk H
    World J Gastroenterol; 2020 Feb; 26(5):550-561. PubMed ID: 32089630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZO-2 Is a Master Regulator of Gene Expression, Cell Proliferation, Cytoarchitecture, and Cell Size.
    González-Mariscal L; Gallego-Gutiérrez H; González-González L; Hernández-Guzmán C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.
    Pradhan-Sundd T; Monga SP
    Gene Expr; 2019 Apr; 19(2):69-87. PubMed ID: 30646969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progressive familial intrahepatic cholestasis type 3].
    Lipiński P; Jankowska I
    Dev Period Med; 2018; 22(4):385-389. PubMed ID: 30636238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease.
    Petrescu AD; Kain J; Liere V; Heavener T; DeMorrow S
    Front Endocrinol (Lausanne); 2018; 9():660. PubMed ID: 30483216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol deficiency as a rare cause of neonatal cholestasis.
    Lipiński P; Kot K; Jankowska I; Szalecki M
    Dev Period Med; 2018; 22(3):280-283. PubMed ID: 30281525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.